- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07943338
Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital (SATISCHOL)
A Prospective Observational Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University Hospital
SATISCHOL is a prospective, monocentric observational study designed to assess pain management and quality of care in patients undergoing elective cholecystectomy at Limoges University Hospital, France.
The primary objective is to assess the proportion of patients reporting a visual analogue scale (VAS) pain score below 4 two hours after surgery, in association with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery.
Secondary objectives include assessing early postoperative pain, describing postoperative complications and intraoperative pain management techniques, and evaluating changes in patients' quality of life using the Gastrointestinal Quality of Life Index (GIQLI) and EQ-5D-5L questionnaires. Patient-reported experience will also be assessed using a study-specific questionnaire (PREMS).
A total of 70 participants are expected to be enrolled. Patients will be followed for approximately 3 to 6 weeks after surgery.
Przegląd badań
Status
Szczegółowy opis
Cholecystectomy is one of the most frequently performed surgical procedures worldwide, both in elective and emergency settings. At Limoges University Hospital, 146 elective laparoscopic cholecystectomies were performed in 2024.
Cholecystectomy is indicated for the treatment of various biliary tract conditions, including biliary colic, acute or chronic cholecystitis, gallbladder polyps, gallstone pancreatitis, cholangitis and common bile duct stones.
Laparoscopic cholecystectomy, with achievement of the critical view of safety, is the standard surgical approach.
Patient-reported outcome measures (PROMs) and postoperative satisfaction have become increasingly important in the assessment of surgical outcomes and are considered key components of patient-centred care.
This study aims to assess pain management and quality of care during elective cholecystectomy at Limoges University Hospital.
Postoperative pain will be assessed using the visual analogue scale (VAS) two hours after surgery. Postoperative complications will be recorded and classified according to the Clavien-Dindo classification up to four weeks after surgery.
Intraoperative pain management techniques, including trocar-site infiltration, diaphragmatic dome infiltration with local anaesthetic and transversus abdominis plane (TAP) block, will also be documented.
Quality of life will be assessed before surgery (T0) and at postoperative follow-up (T2) using the GIQLI and EQ-5D-5L questionnaires. Patient experience will be evaluated at T2 using a study-specific PREMS questionnaire.
Data will be collected prospectively from clinical records and patient-completed questionnaires administered during the preoperative consultation and at the postoperative follow-up consultation, approximately 3 to 6 weeks after surgery.
The study is expected to contribute to the continuous improvement of pain management and quality of care for patients undergoing cholecystectomy at Limoges University Hospital.
Typ studiów
Zapisy (Szacowany)
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Niki CHRISTOU, Professor
- Numer telefonu: 05 55 05 55 55
- E-mail: niki.christou@chu-limoges.fr
Kopia zapasowa kontaktu do badania
- Nazwa: Oumar SECK
- E-mail: cheikhououmar.seck@chu-limoges.fr
Lokalizacje studiów
-
-
-
Limoges, Francja, 87042
- Rekrutacyjny
- Chu Limoges
-
Kontakt:
- Niki CHRISTOU, Professor
- Numer telefonu: 05 55 05 55 55 0555058630
- E-mail: niki.christou@chu-limoges.fr
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Patients undergoing elective cholecystectomy, laparoscopic surgery or minimally invasive surgery.
Opis
Inclusion Criteria:
- Age 18 years or older.
- Patients undergoing elective cholecystectomy.
- Patients undergoing laparoscopic surgery or minimally invasive surgery, including conversion to open laparotomy when necessary.
- Patients able to complete questionnaires independently or with the assistance of a caregiver.
- Patients covered by a health insurance scheme.
- Patients who have not objected to participation in the study.
Exclusion Criteria:
- Patients undergoing emergency surgery.
- Patients undergoing cholecystectomy when gallbladder removal is not the primary purpose of the surgical procedure.
- Patients with a history of chronic gastrointestinal disease.
- Patients with known gallbladder cancer.
- Patients scheduled for open laparotomy.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Modele obserwacyjne: COHORT
- Perspektywy czasowe: PROSPECTIVE
Kohorty i interwencje
Grupa / Kohorta |
|---|
|
Patients undergoing elective cholecystectomy
Adult patients undergoing elective cholecystectomy at Limoges University Hospital |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Proportion of patients with a visual analogue scale (VAS) pain
Ramy czasowe: From two hours after surgery to four weeks postoperatively.
|
Proportion of patients with a visual analogue scale (VAS) pain score below 4 two hours after cholecystectomy, associated with the occurrence of no postoperative complication or a grade I early postoperative complication according to the Clavien-Dindo classification, within four weeks after surgery. |
From two hours after surgery to four weeks postoperatively.
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Proportion of patients with a VAS pain score
Ramy czasowe: Two hours after surgery.
|
Proportion of patients with a VAS pain score below 4 two hours after cholecystectomy. |
Two hours after surgery.
|
|
Proportion of patients experiencing early postoperative complications
Ramy czasowe: Up to four weeks after surgery.
|
Proportion of patients experiencing early postoperative complications, classified according to the Clavien-Dindo classification. |
Up to four weeks after surgery.
|
|
Description of intraoperative pain management techniques
Ramy czasowe: During surgery
|
Assessment of intraoperative analgesic techniques used during surgery, including: local anaesthetic infiltration at trocar insertion sites, local anaesthetic infiltration of the diaphragmatic dome, transversus abdominis plane (TAP) block . For each technique performed, the type of local anaesthetic used and the administered dose will be recorded, where applicable. |
During surgery
|
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score
Ramy czasowe: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the total Gastrointestinal Quality of Life Index (GIQLI) score between baseline (T0) and postoperative follow-up (T2) |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Change in the EQ-5D-5L visual analogue scale (VAS)
Ramy czasowe: Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
Change in the EQ-5D-5L visual analogue scale (VAS), corresponding to the patient's self-rated health status today, between baseline (T0) and postoperative follow-up (T2). |
Preoperative assessment (T0) and postoperative assessment at 3 to 6 weeks (T2).
|
|
Description of patient-reported experience using the study-specific PREMS questionnaire
Ramy czasowe: Postoperative assessment at 3 to 6 weeks (T2)
|
Description of patient-reported experience using the study-specific PREMS questionnaire, analysed item by item. |
Postoperative assessment at 3 to 6 weeks (T2)
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Niki CHRISTOU, Professor, University Hospital, Limoges
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
- Ból
- Objawy neurologiczne
- Choroby Układu Nerwowego
- Powikłania pooperacyjne
- Procesy patologiczne
- Choroby Układu Pokarmowego
- Manifestacje neurobehawioralne
- Choroby dróg żółciowych
- Choroby pęcherzyka żółciowego
- Zaburzenia percepcyjne
- Stany patologiczne, oznaki i objawy
- Objawy i symptomy
- Ból, pooperacyjny
- Zapalenie pęcherzyka żółciowego
- Agnozja
- Kamica żółciowa
Inne numery identyfikacyjne badania
- 87RI24_0064 (SATISCHOL)
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Individual participant data collected during this study will not be made publicly available. Data will be handled in accordance with applicable data protection regulations and institutional policies.
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .